Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Protalix BioTherapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
NYSE · Biological Products, (No Diagnostic Substances)
Prev close 2.67 · gapped above the open, then crossed back over prior close. High/low 2.72 at 10:30 am ET, 2.66 at 12:30 pm ET.
101 institutional managers report a position in Protalix BioTherapeutics, Inc. worth $34.6M between them, filed on form 13F for the quarter ending 2026-06-30. 15 of them hold 80% of it, the largest being BlackRock, Inc. at 27.25%.
76 more managers in the register
15 managers hold 80% of the $34.6M institutional base. The other 86 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 77 days old and does not move with the price above it.
PLX (Protalix BioTherapeutics, Inc.) has 4 disclosed suppliers and 4 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: PFE −0.65%, in healthcare.
via Marshall Wace LLP, Stratos Wealth Partners, LTD., Bridgeway Capital Management Inc · 3.05% of PLX, 21.88% of GANX
via Marshall Wace LLP, Bridgeway Capital Management Inc, Hillsdale Investment Management Inc. · 3.05% of PLX, 6.41% of VNCE
via Marshall Wace LLP, Bridgeway Capital Management Inc, Hillsdale Investment Management Inc. +2 more · 3.05% of PLX, 2.95% of INSG
via Marshall Wace LLP, Hillsdale Investment Management Inc., Bridgeway Capital Management Inc · 3.05% of PLX, 4.40% of RAIL
via Marshall Wace LLP, Hillsdale Investment Management Inc., Bridgeway Capital Management Inc · 3.05% of PLX, 4.11% of DWSN
via Marshall Wace LLP, Bridgeway Capital Management Inc, Lazard Asset Management LLC +1 more · 3.05% of PLX, 8.82% of KODK
Managers holding a meaningful stake in PLX also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.